JP Morgan Chase
CNST

JP Morgan Chase’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

JP Morgan Chase’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-628,458
Closed -$21.2M – 7071
2021
Q2 		$21.2M Buy
628,458
+609,971
+3,299% +$15.5M ﹤0.01% 1785
2021
Q1 		$432K Buy
18,487
+4,155
+29% +$126K ﹤0.01% 4764
2020
Q4 		$412K Buy
14,332
+2,890
+25% +$72.7K ﹤0.01% 4482
2020
Q3 		$227K Buy
11,442
+2,302
+25% +$56.2K ﹤0.01% 4303
2020
Q2 		$274K Buy
9,140
+3,011
+49% +$108K ﹤0.01% 4121
2020
Q1 		$192K Buy
6,129
+31
+0.5% +$1.08K ﹤0.01% 4286
2019
Q4 		$287K Buy
6,098
+1,030
+20% +$29.7K ﹤0.01% 4532
2019
Q3 		$33K Buy
5,068
+822
+19% +$6.86K ﹤0.01% 5300
2019
Q2 		$43K Buy
4,246
+398
+10% +$4.43K ﹤0.01% 5237
2019
Q1 		$52K Buy
3,848
+1,779
+86% +$15.9K ﹤0.01% 5118
2018
Q4 		$8K Buy
2,069
+1,134
+121% +$6.84K ﹤0.01% 5481
2018
Q3 		$6K Buy
+935
New +$8.91K ﹤0.01% 5554

JP Morgan Chase's CNST Position: Q3 2021 in Review

JP Morgan Chase sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 628,458 shares — an estimated $21.2M sold.

JP Morgan Chase first reported a position in CNST in Q3 2018 and held it in 12 quarters. The position peaked at $21.2M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • JP Morgan Chase reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • JP Morgan Chase sold 628,458 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $21.2M.
  • JP Morgan Chase first reported a position in Constellation Pharmaceuticals, Inc. in Q3 2018 and held it in 12 quarters.
  • JP Morgan Chase's Constellation Pharmaceuticals, Inc. position peaked at $21.2M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on JP Morgan Chase's 13F filing for Q3 2021, filed 12 Nov 2021.